Frontiers in Microbiology (Dec 2022)

A newly identified interaction between nucleolar NPM1/B23 and the HTLV-I basic leucine zipper factor in HTLV-1 infected cells

  • Zhenlong Liu,
  • Zhenlong Liu,
  • Zhenlong Liu,
  • Émilie Larocque,
  • Émilie Larocque,
  • Yongli Xie,
  • Yong Xiao,
  • Yong Xiao,
  • Guy Lemay,
  • Jean-Marie Peloponese,
  • Jean-Michel Mesnard,
  • Éric Rassart,
  • Éric Rassart,
  • Rongtuan Lin,
  • Shuang Zhou,
  • Yiming Zeng,
  • Hongzhi Gao,
  • Shan Cen,
  • Benoit Barbeau,
  • Benoit Barbeau,
  • Benoit Barbeau,
  • Benoit Barbeau

DOI
https://doi.org/10.3389/fmicb.2022.988944
Journal volume & issue
Vol. 13

Abstract

Read online

Human T-cell leukemia virus type 1 is the causative agent of HTLV-1-associated myelopathy/tropical spastic paraparesis and adult T-cell leukemia-lymphoma (ATL). The HTLV-1 basic leucine zipper factor (HBZ) has been associated to the cancer-inducing properties of this virus, although the exact mechanism is unknown. In this study, we identified nucleophosmin (NPM1/B23) as a new interaction partner of HBZ. We show that sHBZ and the less abundant uHBZ isoform interact with nucleolar NPM1/B23 in infected cells and HTLV-1 positive patient cells, unlike equivalent antisense proteins of related non-leukemogenic HTLV-2, −3 and-4 viruses. We further demonstrate that sHBZ association to NPM1/B23 is sensitive to RNase. Interestingly, sHBZ was shown to interact with its own RNA. Through siRNA and overexpression experiments, we further provide evidence that NPM1/B23 acts negatively on viral gene expression with potential impact on cell transformation. Our results hence provide a new insight over HBZ-binding partners in relation to cellular localization and potential function on cell proliferation and should lead to a better understanding of the link between HBZ and ATL development.

Keywords